Abi-Saab Walid 4
4 · uniQure N.V. · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
uniQure (QURE) CMO Walid Abi‑Saab Sells 1,434 Shares
What Happened
Walid Abi‑Saab, Chief Medical Officer of uniQure N.V. (QURE), sold 1,434 shares on 2026-06-26 in a transaction that generated approximately $67,197 in proceeds. The reported weighted-average sale price was $46.86 per share (individual trade prices ranged $46.69–$46.96). This sale was made to cover estimated withholding taxes upon the vesting of restricted share units (RSUs) and was not a discretionary trade by the reporting person.
Key Details
- Transaction date: 2026-06-26 (reported on Form 4 filed 2026-06-30) — filing appears timely.
- Transaction type: Sale (S); reason: automatic sale to satisfy tax withholding on vested RSUs (per footnote).
- Shares sold: 1,434; weighted-average price: $46.86; price range: $46.69–$46.96.
- Approximate proceeds: $67,197.
- Shares owned after transaction: Not disclosed in the provided filing.
- Footnotes: F1 — sale executed automatically to cover tax withholding (not discretionary). F2 — weighted-average price; reporting person will provide breakdown of number of shares sold at each price on request.
Context
Sales to cover tax withholding on vested RSUs are routine and are generally considered administrative rather than a signal of the insider’s view on the stock. Purchases tend to be more informative about insider sentiment; this transaction reflects standard RSU vesting mechanics.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-06-26$46.86/sh−1,434$67,197→ 168,235 total
Footnotes (2)
- [F1]The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.69 to $46.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.